A metagenomic study of the gut microbiome in Behcet's disease/Experiment 4

From BugSigDB


Reviewed Marked as Reviewed by ChiomaBlessing on 2024-3-29

Curated date: 2024/03/29

Curator: ChiomaBlessing

Revision editor(s): ChiomaBlessing

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Behcet's syndrome Adamantiades-Behcet disease,BD,Bechet syndrome,BEHCET DIS,Behcet Disease,Behcet disease,Behcet syndrome,Behcet's disease,Behcet's syndrome,Behcets Syndrome,Behet's syndrome,Behet's syndrome (disorder),Behçet disease,Behçet syndrome,Behçet's disease,Behçet's syndrome,Behçet-Adamantiades syndrome,Behçet’s disease,Morbus Behçet's syndrome,silk road disease,triple symptom complex,Triple-Symptom Complex,behcet's syndrome
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Control
Group 1 name Corresponds to the case (exposed) group for case-control studies
Untreated active Behcet's disease (BD) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Active BD was defined according to presence of active intraocular inflammation (case-control)
Group 0 sample size Number of subjects in the control (unexposed) group
52
Group 1 sample size Number of subjects in the case (exposed) group
24
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
1 month

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Mann-Whitney (Wilcoxon)
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
Matched on Factors on which subjects have been matched on in a case-control study
age, body mass index, sex


Signature 1

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-3-29

Curated date: 2024/03/29

Curator: ChiomaBlessing

Revision editor(s): ChiomaBlessing

Source: Supplemental. Table S3

Description: Enriched/ depleted species in Behcet's disease subjects compared to healthy controls

Abundance in Group 1: increased abundance in Untreated active Behcet's disease (BD) patients

NCBI Quality ControlLinks
Atkinsonella texensis
Epichloe aotearoae
Macrophomina phaseolina
Stenotrophomonas sp. Leaf70
Diaporthe ampelina
Colletotrichum higginsianum
Drechslerella stenobrocha
Trichoderma parareesei
Cladophialophora psammophila
Colletotrichum orbiculare
Stenotrophomonas rhizophila
Actinomyces sp. ph3
Candida parapsilosis
Claviceps paspali
Corynebacterium argentoratense
Exophiala mesophila
Ogataea methanolica
Actinomyces graevenitzii
Stenotrophomonas maltophilia
Shiraia sp. slf14
Neurospora crassa

Revision editor(s): ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-3-29

Curated date: 2024/03/29

Curator: ChiomaBlessing

Revision editor(s): ChiomaBlessing

Source: Supplemental. Table S3

Description: Enriched/ depleted species in Behcet's disease subjects compared to healthy controls

Abundance in Group 1: decreased abundance in Untreated active Behcet's disease (BD) patients

NCBI Quality ControlLinks
Acinetobacter sp. CAG:196
Epichloe glyceriae

Revision editor(s): ChiomaBlessing